|
|
|
|
| LEADER |
01572nam a22002775i 4500 |
| 001 |
000289173 |
| 005 |
20210526100111.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100716s2010 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781441964182
|
| 024 |
7 |
|
|a 10.1007/978-1-4419-6418-2
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 100 |
1 |
|
|a Turner, J. Rick.
|e author.
|
| 245 |
1 |
0 |
|a New Drug Development :
|b An Introduction to Clinical Trials: Second Edition /
|c by J. Rick Turner.
|
| 250 |
|
|
|a 2nd ed. 2010.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2010.
|
| 300 |
|
|
|a XXV, 256 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a New Drug Development -- The Regulatory Environment -- Drug Discovery -- Nonclinical Research -- Designing Clinical Trials -- Conducting Clinical Trials I: Experimental Methodology -- Conducting Clinical Trials II: Operational Execution -- Statistical Analysis -- Statistical Significance -- Clinical Significance -- Sample Size Estimation -- General Safety Assessments -- Efficacy Assessment -- Cardiac and Cardiovascular Safety Assessments -- Manufacturing Small Molecule Drugs and Biologicals -- Postmarketing Surveillance -- Main Themes and Concluding Comments.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
1 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|